- idUS
- Browsing by Author
Browsing by Author "Romero Gómez, Manuel"
Now showing items 1-20 of 106
-
Article
A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe
Lazarus, Jeffrey V.; Ekstedt, Mattias; Marchesini, Giulio; Mullen, Jillian; Novak, Katja; Pericàs, Juan M.; Romero Gómez, Manuel; Anstee, Quentin M. (Elsevier, 2020)Background & Aims: Non-alcoholic fatty liver disease (NAFLD) is a growing public health problem worldwide and has become ...
-
Article
A Global Survey of Physicians Knowledge About Nonalcoholic Fatty Liver Disease
Younossi, Zobair M.; Ong, Janus P.; Takahashi, Hirokazu; Yilmaz, Yusuf; Eguc‘hi, Yuichiro; El Kassas, Mohamed; Romero Gómez, Manuel; Stepanova, Maria (Elsevier, 2022)Background & Aims Despite rapidly increasing nonalcoholic fatty liver disease (NAFLD) prevalence, providers’ knowledge ...
-
Article
A machine learning approach enables quantitative measurement of liver histology and disease monitoring in NASH
Taylor-Weiner, Amaro; Pokkalla, Harsha; Han, Ling; Jia, Catherine; Huss, Ryan; Chung, Chuhan; Romero Gómez, Manuel; Younossi, Zobair M. (Wiley, 2021)BACKGROUND AND AIMS: Manual histological assessment is currently the accepted standard for diagnosing and monitoring disease ...
-
Article
A Predictive Model for Selecting Patients with HCV Genotype 3 Chronic Infection with a High Probability of Sustained Virological Response to Peginterferon Alfa-2a/Ribavirin
Asselah, Tarik; Thompson, Ale J.; Flisiak, Robert; Romero Gómez, Manuel; Messinger, Diethelm; Bakalos, Georgios; Shiffman, Mitchell L. (2016-03-18)Background Access to direct-acting antiviral agents (DAAs) is restricted in some settings; thus, the Euro pean Association ...
-
Article
A randomized, controlled trial of the pan-PPAR agonist lanifibranor in NASH
Francque, Sven M.; Bedossa, Pierre; Ratziu, Vlad; Anstee, Quentin M.; Romero Gómez, Manuel; Abdelmalek, Manal F. (Massachusetts Medical Society, 2021)BACKGROUND Management of nonalcoholic steatohepatitis (NASH) is an unmet clinical need. Lanifibranor is a pan-PPAR ...
-
Article
A Shortcut from Metabolic-Associated Fatty Liver Disease (MAFLD) to Hepatocellular Carcinoma (HCC): c-MYC a Promising Target for Preventative Strategies and Individualized Therapy
Guo, Feifei; Estévez-Vázquez, Esther; Benedé-Ubieto, Raquel; Ampuero Herrojo, Javier; Romero Gómez, Manuel; Nevzorova, Yulia A. (2021-12-31)Background: Metabolic-associated fatty liver disease (MAFLD) has risen as one of the leading etiologies for hepatocellular ...
-
Article
A sustainable development goal framework to guide multisectoral action on NAFLD through a societal approach
Lazarus, Jeffrey V.; Mark, Henry E.; Colombo, Massimo; Demaio, Sandro; Dillon, John F.; George, Jacob; Romero Gómez, Manuel; Terry T.K. (Wiley, 2022)Background Non-alcoholic fatty liver disease (NAFLD) is a highly prevalent condition that requires a comprehensive and ...
-
Article
A variant in the MICA gene is associated with liver fbrosis progression in chronic hepatitis C through TGF-β1 dependent mechanisms
El Sharkawy, Rasha; Bayoumi, Ali; Metwally, Mayada; Mangia, Alessandra; Ryberg, Thomas; Romero Gómez, Manuel; Eslam, Mohammed (Nature Research, 2019-02-05)Hepatocarcinogenesis is tightly linked to liver fibrosis. Recently, two GWAS variants, MICA rs2596542 and DEPDC5 rs1012068 ...
-
Article
acNASH index to diagnose nonalcoholic steatohepatitis: a prospective derivation and global validation study
Wu, Xi Xi; Zheng, Kenneth I.; Boursier, Jérôme; Chan, Wah Kheong; Yilmaz, Yusuf; Romero Gómez, Manuel; Zheng, Ming Hua (EClinicalMedicine, 2021)Background There is an unmet need for non-invasive biomarkers for the diagnosis of nonalcoholic steatohepatitis (NASH) ...
-
Article
An experimental DUAL model of advanced liver damage
Benedé-Ubieto, Raquel; Estévez-Vázquez, Olga; Guo, Feifei; Chen, Chaobo; Singh, Youvika; Nakaya, Helder I.; Ampuero Herrojo, Javier; Romero Gómez, Manuel; Nevzorova, Yulia A. (John Wiley & Sons, 2021)Individuals exhibiting an intermediate alcohol drinking pattern in conjunction with signs of metabolic risk present clini ...
-
Article
Analysis of Common Pathways and Markers From Non-Alcoholic Fatty Liver Disease to Immune-Mediated Diseases
Gallego Durán, Rocío; Montero-Vallejo, Rocío; Maya Miles, Douglas; Lucena, Ana; Martin, Franz; Ampuero Herrojo, Javier; Romero Gómez, Manuel (Frontiers Media, 2021-11-24)Metabolic associated fatty liver disease (MAFLD) is the most prevalent form of liver disease worldwide, accounting for a ...
-
Article
Analysis of the burden and variability in the management of NAFLD patients in the clinical practice: unifying the required criteria
Sánchez-Torrijos, Yolanda; Ampuero Herrojo, Javier; Pérez Palacios, Domingo; Gallego Durán, Rocío; Romero Gómez, Manuel (Sociedad Española de Patología Digestiva, 2019)Aim: to assess the prevalence of non-alcoholic fatty liver disease (NAFLD) in the gastroenterology outpatient clinic and ...
-
PhD Thesis
El antígeno de células neoplásicas escamosas (SCCA) solo o formando el complejo SCCA-igM es un biomarcador precoz de carcinoma hepatocelular.
Liu, Changhai (2018-07-11)Background: Hepatocellular carcinoma (HCC) represents more than 90% of primary liver cancers and is a major health problem. ...
-
PhD Thesis
Aplicación clínica de la elastografía por resonancia magnética en la enfermedad hepática crónica
Liang, Jiaxu (2023-02-21)Aims: Aim 1: Comparing the diagnostic accuracy of magnetic resonance elastography (MRE) with ultrasound elastography and ...
-
PhD Thesis
Aproximación proteómica cuantitativa del enterocito y su relación con la encefalopatía hepática
Collantes de Terán, Laura (2008-01-20) -
Article
Assessing the impact of COVID-19 on liver cancer management (CERO-19)
Muñoz-Martínez, S.; Sapena, V.; Forner, A.; Nault, J. C.; Sapisochin, G.; Rimassa, L.; Romero Gómez, Manuel; Reig, M. (Elsevier BV, 2021)Background & Aims: The coronavirus disease 2019 (COVID-19) pandemic has posed unprecedented challenges to healthcare systems ...
-
Article
Assessing the Impact of SARS-CoV-2 Lineages and Mutations on Patient Survival
Loucera, Carlos; Perez-Florido, Javier; Casimiro-Soriguer, Carlos S.; Ortuno, Francisco M.; Carmona, Rosario; Bostelmann, Gerrit; Rodríguez-Baño, Jesús; Romero Gómez, Manuel; Lepe Jiménez, José Antonio; Dopazo, Joaquin (MDPI, 2022)Objectives: More than two years into the COVID-19 pandemic, SARS-CoV-2 still remains a global public health problem. ...
-
Article
Bacterial infections in patients with acute variceal bleeding in the era of antibiotic prophylaxis
Martínez, Javier; Hernández-Gea, Virginia; Rodríguez de Santiago, Enrique; Téllez, Luis; Procopet, Bogdan; Giráldez, Álvaro; Romero Gómez, Manuel; Albillos, Agustín (Elsevier Science, 2021-08)Background & Aims Antibiotic prophylaxis reduces the risk of infection and mortality in patients with cirrhosis and acute ...
-
PhD Thesis
Biopsychosocial profile of non-alcoholic fatty liver disease (NAFLD) associated with liver transplantation and prevention of risk factors
Funuyet Salas, Jesús (2022-11-16)En la presente Tesis Doctoral se han llevado a cabo un estudio teórico y cinco trabajos empíricos y pioneros que abordan ...
-
Article
Case Report: Acute-on-Chronic Liver Failure: Making the Diagnosis between Infection and Acute Alcoholic Hepatitis
Sendra, Carmen; Ampuero Herrojo, Javier; Giráldez Gallego, Álvaro; Sousa, José Manuel; Romero Gómez, Manuel (Thieme Medical Publishers, 2016-06)Acute-on-chronic liver failure (ACLF) represents a reversible syndrome associated with high short-term mortality, characterized ...